Kanto Central Hospital, Tokyo, Japan Yotsuya-Shirato Eye Clinic, Tokyo, Japan.
Acta Ophthalmol. 2012 Aug;90(5):e337-43. doi: 10.1111/j.1755-3768.2012.02425.x. Epub 2012 May 2.
To prospectively study prognostic factors for normal-tension glaucoma (NTG) under treatment with topical β-blocker.
One hundred and forty-six eyes of 146 patients with NTG with a mean untreated intraocular pressure (IOP) of 14 mmHg, mild to moderate visual field damage and mean spherical equivalent refraction of -3.5 (-8.0 to +2.0) dioptre were randomized to topical nipradilol or timolol and followed for 3 years. The Humphrey full threshold 30-2 visual field test was performed every 6 months, and optic disc photographs were obtained every 12 months. Progression was defined as visual field progression, optic disc and/or peripapillary nerve fibre layer change, and factors relating to progression were evaluated using Cox proportional hazards models.
IOP decreased by 1.0 mmHg over the 3-year period, during which 35% showed progression according to the aforementioned criteria. Optic disc haemorrhage (hazard ratio [HR] 4.00, p < 0.001) and less extent of myopia (per dioptre, HR 1.15, p = 0.013) were significant risk factors. When progression was defined by visual field progression only, less extent of myopia was again a significant risk factor (HR 1.17, p = 0.038).
Beside optic disc haemorrhage, less extent of myopia was a risk factor for progression in the current NTG population where most patients were mildly myopic and IOP during follow-up averaged 13.2 mmHg under topical β-blocker.
前瞻性研究局部用β受体阻滞剂治疗下正常眼压性青光眼(NTG)的预后因素。
146 例 NTG 患者 146 只眼纳入研究,这些患者未治疗时的平均眼内压(IOP)为 14mmHg,视野损害程度较轻至中度,平均等效球镜屈光度为-3.5(-8.0 至+2.0)屈光度。将这些患者随机分为局部用尼普地洛或噻吗洛尔组,并随访 3 年。每 6 个月进行一次 Humphrey 全阈值 30-2 视野检查,每 12 个月进行一次视盘照相。将视野进展、视盘和/或神经纤维层改变定义为进展,并使用 Cox 比例风险模型评估与进展相关的因素。
在 3 年期间,IOP 下降了 1.0mmHg,其中 35%的患者根据上述标准出现进展。视盘出血(危险比[HR]4.00,p<0.001)和近视程度较低(每 1.0 屈光度,HR 1.15,p=0.013)是显著的危险因素。当仅根据视野进展定义进展时,近视程度较低也是一个显著的危险因素(HR 1.17,p=0.038)。
除视盘出血外,在当前 NTG 人群中,近视程度较低也是进展的危险因素,在该人群中,大多数患者为轻度近视,在局部用β受体阻滞剂治疗期间,随访期间的平均 IOP 为 13.2mmHg。